Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: A4ID93
Term | Name | Level | Count |
---|---|---|---|
GO:0006996 | organelle organization | 4 | 11 |
GO:0007031 | peroxisome organization | 5 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016043 | cellular component organization | 3 | 11 |
GO:0071840 | cellular component organization or biogenesis | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 109 | 111 | PF00082 | 0.524 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.479 |
CLV_PCSK_PC1ET2_1 | 109 | 111 | PF00082 | 0.517 |
CLV_PCSK_PC1ET2_1 | 58 | 60 | PF00082 | 0.463 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.423 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.364 |
CLV_Separin_Metazoa | 35 | 39 | PF03568 | 0.324 |
DEG_APCC_DBOX_1 | 58 | 66 | PF00400 | 0.312 |
DOC_CYCLIN_RxL_1 | 72 | 82 | PF00134 | 0.449 |
DOC_MAPK_gen_1 | 109 | 117 | PF00069 | 0.475 |
DOC_MAPK_gen_1 | 58 | 64 | PF00069 | 0.440 |
DOC_MAPK_MEF2A_6 | 90 | 98 | PF00069 | 0.349 |
DOC_PP1_RVXF_1 | 73 | 79 | PF00149 | 0.390 |
DOC_USP7_MATH_1 | 41 | 45 | PF00917 | 0.437 |
LIG_14-3-3_CanoR_1 | 110 | 116 | PF00244 | 0.489 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.440 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.447 |
LIG_FHA_1 | 87 | 93 | PF00498 | 0.471 |
LIG_LIR_Gen_1 | 82 | 92 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 82 | 88 | PF02991 | 0.462 |
LIG_Pex14_1 | 18 | 22 | PF04695 | 0.328 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.329 |
LIG_SUMO_SIM_anti_2 | 114 | 119 | PF11976 | 0.402 |
LIG_UBA3_1 | 1 | 7 | PF00899 | 0.553 |
LIG_UBA3_1 | 61 | 66 | PF00899 | 0.500 |
MOD_Cter_Amidation | 10 | 13 | PF01082 | 0.470 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.393 |
MOD_NEK2_1 | 96 | 101 | PF00069 | 0.503 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.214 |
MOD_Plk_4 | 92 | 98 | PF00069 | 0.404 |
TRG_ENDOCYTIC_2 | 85 | 88 | PF00928 | 0.355 |
TRG_ER_diArg_1 | 73 | 76 | PF00400 | 0.439 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7N3 | Leptomonas seymouri | 73% | 68% |
A0A0S4JN26 | Bodo saltans | 28% | 73% |
A0A1X0NKF5 | Trypanosomatidae | 48% | 72% |
A0A3S7XB48 | Leishmania donovani | 100% | 100% |
A0A422NM43 | Trypanosoma rangeli | 43% | 71% |
A4HPH1 | Leishmania braziliensis | 92% | 100% |
D0A3I1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 72% |
E9AT83 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4Q1B4 | Leishmania major | 96% | 100% |
V5BKE1 | Trypanosoma cruzi | 43% | 71% |